Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fidock

Showing results (171-180 of 303) with videos related to

Pageof 31
Sort By:
Biorxiv : the Preprint Server for Biology|August 20, 2025
Recombinant proteasome provides new avenues for anti-malarial drug developmentPavla Fajtova, Hanxiao Zhang, Liam Urich, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Novel diaryl ureas with efficacy in a mouse model of malariaJohn W Anderson, Dimitri Sarantakis, Jacek Terpinski, et al.
Bioorganic & Medicinal Chemistry|February 7, 2009
Select pyrimidinones inhibit the propagation of the malarial parasite, Plasmodium falciparumAnnette N Chiang, Juan-Carlos Valderramos, Raghavan Balachandran, et al.
Plos Pathogens|April 21, 2020
Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13Nina F Gnädig, Barbara H Stokes, Rachel L Edwards, et al.
Mbio|May 11, 2017
A Variant PfCRT Isoform Can Contribute to <i>Plasmodium falciparum</i> Resistance to the First-Line Partner Drug PiperaquineSatish K Dhingra, Devasha Redhi, Jill M Combrinck, et al.
Nature Medicine|August 5, 2020
Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in RwandaAline Uwimana, Eric Legrand, Barbara H Stokes, et al.
Genome Biology|February 17, 2009
Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparumNeekesh V Dharia, Amar Bir Singh Sidhu, María Belén Cassera, et al.
The Lancet. Infectious Diseases|April 2, 2017
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised studyJames S McCarthy, Julie Lotharius, Thomas Rückle, et al.
Nature Medicine|May 28, 2021
Author Correction: Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in RwandaAline Uwimana, Eric Legrand, Barbara H Stokes, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2024
Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugsAngélica M Rosado-Quiñones, Emilee E Colón-Lorenzo, Zarna Rajeshkumar Pala, et al.
Pageof 31

Showing results (171-180 of 303) with videos related to

Sort By:
Pageof 31
Biorxiv : the Preprint Server for Biology|August 20, 2025
Recombinant proteasome provides new avenues for anti-malarial drug developmentPavla Fajtova, Hanxiao Zhang, Liam Urich, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Novel diaryl ureas with efficacy in a mouse model of malariaJohn W Anderson, Dimitri Sarantakis, Jacek Terpinski, et al.
Bioorganic & Medicinal Chemistry|February 7, 2009
Select pyrimidinones inhibit the propagation of the malarial parasite, Plasmodium falciparumAnnette N Chiang, Juan-Carlos Valderramos, Raghavan Balachandran, et al.
Plos Pathogens|April 21, 2020
Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13Nina F Gnädig, Barbara H Stokes, Rachel L Edwards, et al.
Mbio|May 11, 2017
A Variant PfCRT Isoform Can Contribute to <i>Plasmodium falciparum</i> Resistance to the First-Line Partner Drug PiperaquineSatish K Dhingra, Devasha Redhi, Jill M Combrinck, et al.
Nature Medicine|August 5, 2020
Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in RwandaAline Uwimana, Eric Legrand, Barbara H Stokes, et al.
Genome Biology|February 17, 2009
Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparumNeekesh V Dharia, Amar Bir Singh Sidhu, María Belén Cassera, et al.
The Lancet. Infectious Diseases|April 2, 2017
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised studyJames S McCarthy, Julie Lotharius, Thomas Rückle, et al.
Nature Medicine|May 28, 2021
Author Correction: Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in RwandaAline Uwimana, Eric Legrand, Barbara H Stokes, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2024
Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugsAngélica M Rosado-Quiñones, Emilee E Colón-Lorenzo, Zarna Rajeshkumar Pala, et al.
Pageof 31